pascolizumab
E2190224
UNEXPLORED
Pascolizumab is a humanized monoclonal antibody drug candidate designed to neutralize interleukin-4 for the treatment of allergic and inflammatory conditions such as asthma.
All labels observed (1)
| Label | Occurrences |
|---|---|
| pascolizumab canonical | 1 |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.